Evidence map›Paper›PMID 36284538›Full record

ArticleChina CDC weekly2022

Promote COVID-19 Vaccination for Older Adults in China.

Shujie Zang, Xu Zhang, Zhiqiang Qu, Xi Chen, Zhiyuan Hou

2 registry-linked trialsOpen access · diamondAbstract read
In one paragraph

Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06227689 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Evaluation of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination for Middle School Girls in China: a Randomized Controlled Trial and Implementation Science Study

TypeinterventionalSponsorFudan UniversityRan2024 to 2024Enrolled1,800ConditionsHPV VaccineArmsVaccine chatbot that offering HPV vaccine-related information
NCT07200570 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy: a Randomized Controlled Trial and Implementation Science Study

TypeinterventionalSponsorFudan UniversityRan2026 to 2026Enrolled1,800ConditionsHPV VaccineArmsLLM-Powered HPV Vaccine Chatbot
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shujie ZangSchool of Public Health, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai Municipality, China.
Xu ZhangSchool of Public Health, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai Municipality, China.
Zhiqiang QuSchool of Public Health, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai Municipality, China.
Xi ChenDepartment of Health Policy and Management, School of Public Health, Yale University, New Haven, CT, USA.
Zhiyuan HouSchool of Public Health, NHC Key Laboratory of Health Technology Assessment, Fudan University, Shanghai Municipality, China.
Yale University · US

Funding

Social Pension, Health, and Healthy AgingK01AG053408 · NIA · YALE UNIVERSITY · PI CHEN, XI · 2018 to 2021
$514k
NIA NIH HHS K01 AG053408
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChinaCOVID-19 vaccinationolder adultspromotion

Identifiers

PMID36284538
PMCPMC9547737
OpenAlexW4296281002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.